Cargando…
Reinvestigating the clinical relevance of the m(6)A writer METTL3 in urothelial carcinoma of the bladder
METTL3 is the major writer of N6-Methyladenosine (m(6)A) and has been associated with controversial roles in cancer. This is best illustrated in urothelial carcinoma of the bladder (UCB), where METTL3 was described to have both oncogenic and tumor-suppressive functions. Here, we reinvestigated the r...
Autores principales: | Koch, Jonas, Neuberger, Manuel, Schmidt-Dengler, Martina, Xu, Jinyun, Carneiro, Vitor Coutinho, Ellinger, Jörg, Kriegmair, Maximilian C., Nuhn, Philipp, Erben, Philipp, Michel, Maurice Stephan, Helm, Mark, Rodríguez-Paredes, Manuel, Nientiedt, Malin, Lyko, Frank |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10405067/ https://www.ncbi.nlm.nih.gov/pubmed/37554463 http://dx.doi.org/10.1016/j.isci.2023.107300 |
Ejemplares similares
-
An m6A-Driven Prognostic Marker Panel for Renal Cell Carcinoma Based on the First Transcriptome-Wide m6A-seq
por: Waldbillig, Frank, et al.
Publicado: (2023) -
Downregulation of m(6)A writer complex member METTL14 in bladder urothelial carcinoma suppresses tumor aggressiveness
por: Guimarães‐Teixeira, Catarina, et al.
Publicado: (2022) -
The Comprehensive Analysis of N6-Methyadenosine Writer METTL3 and METTL14 in Gastric Cancer
por: Ge, Yiling, et al.
Publicado: (2023) -
Phosphodiesterase SMPDL3B Gene Expression as Independent Outcome Prediction Marker in Localized Prostate Cancer
por: Waldbillig, Frank, et al.
Publicado: (2020) -
Changes in neutrophile-to-lymphocyte ratio as predictive and prognostic biomarker in metastatic prostate cancer treated with taxane-based chemotherapy
por: Neuberger, Manuel, et al.
Publicado: (2022)